Rothschild Investment Corp Gilead Sciences, Inc. Transaction History

Rothschild Investment Corp

$1.19 Billion
Q3 2023

A detailed history of Rothschild Investment Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rothschild Investment Corp holds 4,447 shares of GILD stock, worth $376,171. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,447

Previous 4,623 3.81%

Holding current value

$376,171

Previous $356,000 6.46%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$73.94 - $80.67 $13,013 - $14,197	-176 Reduced 3.81%	4,447 $333,000
Q2 2023 Jul 18, 2023	BUY	$76.01 - $86.7 $21,890 - $24,969	288 Added 6.64%	4,623 $356,000
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $71,668 - $102,890	-1,150 Reduced 20.97%	4,335 $372,000
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $12,684 - $15,895	-219 Reduced 3.84%	5,485 $326,000
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $9,732 - $11,046	-150 Reduced 2.56%	5,704 $414,000
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $47,412 - $51,804	747 Added 14.63%	5,854 $403,000
Q1 2021 Apr 15, 2021	BUY	$60.0 - $68.46 $5,820 - $6,640	97 Added 1.94%	5,107 $330,000
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $167,174 - $190,487	-2,951 Reduced 37.07%	5,010 $292,000
Q2 2020 Jul 24, 2020	BUY	$72.34 - $84.0 $153,794 - $178,584	2,126 Added 36.44%	7,961 $613,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $51,356 - $65,780	-820 Reduced 12.32%	5,835 $436,000
Q3 2019 Oct 11, 2019	SELL	$62.51 - $69.0 $18,753 - $20,700	-300 Reduced 4.31%	6,655 $422,000
Q2 2019 Jul 11, 2019	SELL	$61.87 - $69.38 $30,935 - $34,690	-500 Reduced 6.71%	6,955 $470,000
Q1 2019 Apr 18, 2019	SELL	$62.53 - $70.05 $284,511 - $318,727	-4,550 Reduced 37.9%	7,455 $485,000
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $59,329 - $77,420	-980 Reduced 7.55%	12,005 $751,000
Q3 2018 Oct 17, 2018	SELL	$71.28 - $78.92 $99,435 - $110,093	-1,395 Reduced 9.7%	12,985 $1 Million
Q2 2018 Jul 24, 2018	SELL	$64.88 - $75.68 $4,866 - $5,676	-75 Reduced 0.52%	14,380 $1.02 Million
Q1 2018 Apr 27, 2018	BUY	$72.84 - $88.8 $13,475 - $16,428	185 Added 1.3%	14,455 $1.09 Million
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $361,726 - $424,615	-5,084 Reduced 26.27%	14,270 $1.02 Million
Q3 2017 Oct 25, 2017	BUY	$72.11 - $85.47 $1.4 Million - $1.65 Million	19,354	19,354 $1.57 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.

Account

Rothschild Investment Corp Gilead Sciences, Inc. Transaction History